BTAI - BioXcel Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BTAI is currently covered by 9 analysts with an average price target of $19.43. This is a potential upside of $18.22 (1505.79%) from yesterday's end of day stock price of $1.21.

BioXcel Therapeutics's activity chart (see below) currently has 92 price targets and 107 ratings on display. The stock rating distribution of BTAI is 76.09% BUY and 23.91% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.26% with an average time for these price targets to be met of 172 days.

Highest price target for BTAI is $10, Lowest price target is $4, average price target is $19.43.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 27-Jun-2024. First documented stock forecast 02-Apr-2018.

Currently out of the existing stock ratings of BTAI, 35 are a BUY (76.09%), 11 are a HOLD (23.91%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$5.79 (478.51%)

18

17 days ago

4/17 (23.53%)

$5.73 (451.18%)

251

Buy

10

$8.79 (726.45%)

10

2 months 4 days ago

2/26 (7.69%)

$7.91 (378.47%)

345

Buy

7

$5.79 (478.51%)

23

4 months 1 days ago

2/7 (28.57%)

$4.13 (143.90%)

342

Hold

4

$2.79 (230.58%)

9

4 months 23 days ago

2/7 (28.57%)

$0.85 (26.98%)

305

Hold

9 months 9 days ago

0/8 (0%)

$93.32 (294.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTAI (BioXcel Therapeutics) average time for price targets to be met?

On average it took 172 days on average for the stock forecasts to be realized with a an average price target met ratio 35.26

Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on BTAI

Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?

Do Kim with highest potential upside - $93.79

Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?

Robyn Karnauskas with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?